Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Hypertension2364 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A49460 | 35744822 | Molecules | Neuroendocrine-Immune Regulatory Network of Eucommia ulmoides Oliver. | 2022 | Details |
| A49490 | 35739488 | Int J Emerg Med | Medical complications of obesity: heightened importance in a COVID era. | 2022 | Details |
| A49516 | 35728961 | Cas Lek Cesk | Diagnosis of non-alcoholic fatty liver disease and its active screening in risk groups. | 2022 | Details |
| A49529 | 35725419 | BMC Pregnancy Childbirth | The association between chronic liver diseases and preeclampsia. | 2022 | Details |
| A49547 | 35719604 | Front Public Health | Australian State and Territory Eclectic Approaches to Obesity Prevention in the Early Years: Policy Mapping and Perspectives of Senior Health Officials. | 2022 | Details |
| A49579 | 35708049 | Crit Rev Food Sci Nutr | Health benefits of astaxanthin against age-related diseases of multiple organs: A comprehensive review. | 2022 | Details |
| A49586 | 35702844 | J Assoc Physicians India | A Study on FibroScan and Endoscopic Finding in Patients of Chronic Liver Disease attending Tripura Medical College and Dr. B.R. Ambedkar Memorial Teaching Hospital. | 2022 | Details |
| A49587 | 35702836 | J Assoc Physicians India | Interrelation of the Risk Factors of NAFLD at various Stages of Progression of the glycemic Status on long-term Follow-up. | 2022 | Details |
| A49590 | 35700934 | Ann Hepatol | The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study. | 2022 | Details |
| A49617 | 35690264 | J Hepatol | Porto-sinusoidal vascular disorder. | 2022 | Details |
| A49625 | 35688225 | Environ Res | PM2.5 air pollution exposure and nonalcoholic fatty liver disease in the Nationwide Inpatient Sample. | 2022 | Details |
| A49660 | 35677506 | J Clin Exp Hepatol | Value of Liver Function Tests in Cirrhosis. | 2021 | Details |
| A49683 | 35672152 | Pharm Biol | Camel milk protein hydrosylate alleviates hepatic steatosis and hypertension in high fructose-fed rats. | 2022 | Details |
| A49688 | 35670897 | Dig Dis Sci | Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria. | 2022 | Details |
| A49705 | 35663319 | Front Endocrinol (Lausanne) | High Prevalence of Cardiometabolic Comorbidities Among Children and Adolescents With Severe Obesity From a Large Metropolitan Centre (Hangzhou, China). | 2022 | Details |
| A49742 | 35651978 | Front Endocrinol (Lausanne) | Non-alcoholic Fatty Liver Disease Is Associated With Aortic Calcification: A Cohort Study With Propensity Score Matching. | 2022 | Details |
| A49745 | 35651599 | Psoriasis (Auckl) | Comorbid Psoriasis and Metabolic Syndrome: Clinical Implications and Optimal Management. | 2022 | Details |
| A49761 | 35644970 | Zhonghua Yu Fang Yi Xue Za Zhi | [The characteristics of non-alcoholic fatty liver disease and its associated factors in patients with rheumatoid arthritis]. | 2022 | Details |
| A49783 | 35639037 | J Physiol Pharmacol | Are insulin resistance and non-alcoholic fatty liver disease associated with Peyronie's disease? A pilot study. | 2022 | Details |
| A49795 | 35635761 | Liver Int | Comparison of point-shear wave elastography (ElastPQ) and transient elastography (FibroScan) for liver fibrosis staging in patients with non-alcoholic fatty liver disease. | 2022 | Details |
| A49824 | 35627987 | Healthcare (Basel) | Association of Low Skeletal Muscle Mass with the Phenotype of Lean Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A49827 | 35625927 | Biomedicines | A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo. | 2022 | Details |
| A49863 | 35615095 | Front Med (Lausanne) | Endoscopic Bariatric and Metabolic Therapies and Their Effects on Metabolic Syndrome and Non-alcoholic Fatty Liver Disease - A Systematic Review and Meta-Analysis. | 2022 | Details |
| A49873 | 35612975 | Nephrol Dial Transplant | Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than does fatty liver or nonalcoholic fatty liver disease. | 2022 | Details |
| A49904 | 35603209 | Front Immunol | Liver Stiffness by Transient Elastography Correlates With Degree of Portal Hypertension in Common Variable Immunodeficiency Patients With Nodular Regenerative Hyperplasia. | 2022 | Details |
| A49906 | 35601123 | JGH Open | Relationship between the prevalence and severity of non-alcoholic fatty liver disease and coronary artery disease: Findings from a cross-sectional study of a referral center in northeast Iran. | 2022 | Details |
| A49910 | 35599922 | Ann Gastroenterol | Emerging advances in the pharmacologic treatment of nonalcoholic steatohepatitis and related cirrhosis. | 2022 | Details |
| A49916 | 35597838 | Hormones (Athens) | Association of hypertriglyceridemic waist phenotype with non-alcoholic fatty liver disease: a cross-sectional study in a Chinese population. | 2022 | Details |
| A49921 | 35595482 | Prim Care | Diabetes-Associated Comorbidities. | 2022 | Details |
| A49934 | 35589256 | J Hepatol | Impact of non-invasive biomarkers on hepatology practice: Past, present and future. | 2022 | Details |
| A49941 | 35587339 | J Clin Endocrinol Metab | Global Prevalence and Clinical Characteristics of Metabolic Associated Fatty Liver Disease. A Meta-Analysis and Systematic Review of 10,739,607 Individuals. | 2022 | Details |
| A49959 | 35582293 | World J Hepatol | Interrelationship between physical activity and depression in nonalcoholic fatty liver disease. | 2022 | Details |
| A49960 | 35582287 | World J Hepatol | Prevalence of hypothyroidism and effect of thyroid hormone replacement therapy in patients with non-alcoholic fatty liver disease: A population-based study. | 2022 | Details |
| A49966 | 35579799 | Dig Dis Sci | MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups. | 2022 | Details |
| A49977 | 35575004 | Hepatol Res | High fatty liver index is an independent predictor of ischemic heart disease during a 10-year period in a Japanese population. | 2022 | Details |
| A49984 | 35572477 | Gastroenterology Res | Burden and Predictors of Non-Alcoholic Fatty Liver Disease in a Retrospective Cohort of Patients With Crohn's Disease. | 2022 | Details |
| A49986 | 35571533 | JHEP Rep | Hepatic decompensation is accelerated in patients with cirrhosis and alpha-1 antitrypsin Pi∗MZ genotype. | 2022 | Details |
| A49990 | 35569823 | Korean J Intern Med | Changes in the prevalence of hepatitis B and metabolic abnormalities among young men in Korea. | 2022 | Details |
| A50071 | 35535099 | J Clin Exp Hepatol | Prevalence of Risk Factors for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Patients With Cryptogenic Cirrhosis. | 2021 | Details |
| A50076 | 35535068 | J Clin Exp Hepatol | FibroScan-AST (FAST) Score for Nonalcoholic Steatohepatitis - Validation in an Indian Cohort. | 2021 | Details |
| A50079 | 35535063 | J Clin Exp Hepatol | Gallstone Disease in Cirrhosis-Pathogenesis and Management. | 2021 | Details |
| A50096 | 35528987 | J Clin Transl Hepatol | Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications. | 2022 | Details |
| A50103 | 35527706 | Hepatol Commun | Nonalcoholic fatty liver disease prevalence and severity in Asian Americans from the national health and nutrition examination surveys 2017-2018. | 2022 | Details |
| A50117 | 35516713 | J Family Med Prim Care | Evaluation of lipoprotein (a) [Lp(a)] and lipid abnormalities in patients with newly detected hypertension and its association with severity of hypertension. | 2022 | Details |
| A50123 | 35512974 | Fertil Steril | Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome. | 2022 | Details |
| A50129 | 35509420 | Therap Adv Gastroenterol | Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver disease. | 2022 | Details |
| A50132 | 35508444 | Eur J Intern Med | Uric acid in metabolic syndrome: Does uric acid have a definitive role? | 2022 | Details |
| A50136 | 35507280 | Curr Atheroscler Rep | Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease. | 2022 | Details |
| A50139 | 35506136 | Radiol Cardiothorac Imaging | Hepatosteatosis and Atherosclerotic Plaque at Coronary CT Angiography. | 2022 | Details |
| A50204 | 35476909 | Angiology | Atherosclerosis and Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50215 | 35470108 | Clin Res Hepatol Gastroenterol | Comparison of screening strategies with two new tests to score and diagnose varices needing treatment. | 2022 | Details |
| A50223 | 35465684 | Hypertension | Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors. | 2022 | Details |
| A50243 | 35460926 | Biomed J | Prognosis of Chronic Kidney Disease in Patients with Non-Alcoholic Fatty Liver Disease: a Northeastern Taiwan Community Medicine Research Cohort. | 2022 | Details |
| A50247 | 35459338 | Klin Onkol | Metabolic syndrome in long-term survivors after allogeneic hematopoietic stem cell transplantation. | 2022 | Details |
| A50256 | 35453652 | Biomedicines | Potential Therapeutic Targets and Promising Agents for Combating NAFLD. | 2022 | Details |
| A50267 | 35449229 | Sci Rep | Transient elastography and serum markers of liver fibrosis associate with epicardial adipose tissue and coronary artery calcium in NAFLD. | 2022 | Details |
| A50278 | 35444985 | Front Public Health | A Machine Learning Based Framework to Identify and Classify Non-alcoholic Fatty Liver Disease in a Large-Scale Population. | 2022 | Details |
| A50283 | 35443534 | J Assoc Physicians India | Correlation Between Carotid Intima Media Thickness and Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50286 | 35443470 | J Assoc Physicians India | A Study of Correlation between Non Alcoholic Fatty Liver Disease and Carotid Atherosclerosis. | 2022 | Details |
| A50288 | 35443385 | J Assoc Physicians India | A Study of Left Ventricular Dysfunction in Normotensive Non Diabetic Patients with Non Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50293 | 35442320 | Arq Gastroenterol | SHOULD ROUTINE LIVER BIOPSY BE CONSIDERED IN BARIATRIC SURGICAL PRACTICE? AN ANALYSIS OF THE LIMITATIONS OF NON-INVASIVE NAFLD MARKERS. | 2022 | Details |
| A50324 | 35433761 | Front Med (Lausanne) | Quantitative Assessment of Portal Hypertension by Two-Dimensional Shear Wave Elastography in Rat Models of Nonalcoholic Fatty Liver Disease: Comparison With Four Composite Scores. | 2022 | Details |
| A50333 | 35430032 | Lancet Gastroenterol Hepatol | The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas. | 2022 | Details |
| A50336 | 35429258 | Cardiovasc Toxicol | Interplay of Obesity, Ethanol, and Contaminant Mixture on Clinical Profiles of Cardiovascular and Metabolic Diseases: Evidence from an Animal Study. | 2022 | Details |
| A50374 | 35412487 | Eur J Gastroenterol Hepatol | Left ventricular strain predicts subclinical atherosclerosis in nonadvanced nonalcoholic fatty liver disease patients. | 2022 | Details |
| A50377 | 35412016 | Clin Obes | The impact of health status, diet and lifestyle on non-alcoholic fatty liver disease: Narrative review. | 2022 | Details |
| A50379 | 35411570 | Hepatol Commun | Effect of hepatic steatosis and associated metabolic comorbidities on health-related quality of life in people living with HIV. | 2022 | Details |
| A50380 | 35411023 | J Hum Hypertens | Association between hypertension and nonalcoholic fatty liver disease: a cross-sectional and meta-analysis study. | 2022 | Details |
| A50415 | 35399831 | J Healthc Eng | Associations of Urinary Phytoestrogen Concentrations with Nonalcoholic Fatty Liver Disease among Adults. | 2022 | Details |
| A50427 | 35396116 | Endocrinol Diabetes Nutr (Engl Ed) | Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity. | 2022 | Details |
| A50440 | 35391786 | J Lipids | Age- and Diet-Dependent Changes in Hepatic Lipidomic Profiles of Phospholipids in Male Mice: Age Acceleration in Cyp2b-Null Mice. | 2022 | Details |
| A50448 | 35386695 | Front Immunol | Systemic Immune-Inflammation Index Is Associated With Increased Urinary Albumin Excretion: A Population-Based Study. | 2022 | Details |
| A50451 | 35385529 | PLoS One | Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals. | 2022 | Details |
| A50467 | 35378561 | Horm Metab Res | The Negative Association Between NAFLD Severity and CKD in a Non-Diabetic Gouty Population. | 2022 | Details |
| A50477 | 35371259 | Int J Endocrinol | Bidirectional Association between Hypertension and NAFLD: A Systematic Review and Meta-Analysis of Observational Studies. | 2022 | Details |
| A50515 | 35356372 | Oman Med J | Prevalence of Non-alcoholic Fatty Liver Disease among Patients with Diabetes Mellitus Attending Primary Health Care Centers in Bahrain. | 2022 | Details |
| A50529 | 35352691 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease: opinions, population served, and management from a sample of French hepato(gastroentero)logists (PERSEPT study). | 2022 | Details |
| A50554 | 35343663 | Minerva Gastroenterol (Torino) | Associations between muscle mass, strength, and performance and non-alcoholic fatty liver disease. | 2022 | Details |
| A50571 | 35334964 | Nutrients | Selected Organ and Endocrine Complications According to BMI and the Metabolic Category of Obesity: A Single Endocrine Center Study. | 2022 | Details |
| A50576 | 35334784 | Nutrients | Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review. | 2022 | Details |
| A50586 | 35332431 | Intern Emerg Med | Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity. | 2022 | Details |
| A50602 | 35328503 | Int J Mol Sci | The Endocannabinoid System and Physical Activity-A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders. | 2022 | Details |
| A50606 | 35327522 | Biomedicines | Metabolic Syndrome but Not Fatty Liver-Associated Genetic Variants Correlates with Glomerular Renal Function Decline in Patients with Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50696 | 35296520 | Open Heart | Coenzyme Q10 deficiency can be expected to compromise Sirt1 activity. | 2022 | Details |
| A50699 | 35295895 | Visc Med | Metabolic Surgery: Paradigm Shift in Metabolic Syndrome/Diabetes Therapy. | 2022 | Details |
| A50704 | 35294323 | Platelets | Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis. | 2022 | Details |
| A50721 | 35287643 | BMC Endocr Disord | Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. | 2022 | Details |
| A50749 | 35278680 | Ann Hepatol | Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease. | 2022 | Details |
| A50750 | 35278405 | Eur J Pharmacol | Inonotus obliquus and its bioactive compounds alleviate non-alcoholic fatty liver disease via regulating FXR/SHP/SREBP-1c axis. | 2022 | Details |
| A50765 | 35275232 | World J Surg | Bariatric Surgery is Effective and Safe for Obese Patients with Compensated Cirrhosis: A Systematic Review and Meta-Analysis. | 2022 | Details |
| A50767 | 35274325 | Aliment Pharmacol Ther | Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease. | 2022 | Details |
| A50782 | 35268536 | J Clin Med | Hyperuricemia Is Associated with Significant Liver Fibrosis in Subjects with Nonalcoholic Fatty Liver Disease, but Not in Subjects without It. | 2022 | Details |
| A50813 | 35206282 | Int J Environ Res Public Health | Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease among 73,566 Individuals in Beijing, China. | 2022 | Details |
| A50817 | 35194872 | J Intern Med | Uncontrolled hypertension: A neglected risk in patients with NAFLD. | 2022 | Details |
| A50818 | 35170370 | Scand J Gastroenterol | Effect of serum vitamin D on metabolic associated fatty liver disease: a large population-based study. | 2022 | Details |
| A50848 | 34984757 | J Intern Med | Regarding: Pulmonary hypertension is associated with an increased incidence of NAFLD. | 2022 | Details |
| A50849 | 34984738 | J Intern Med | Authors' reply: Pulmonary hypertension is associated with an increased incidence of NAFLD. | 2022 | Details |
| A50870 | 34728983 | J Clin Exp Hepatol | Predictors of in-hospital Outcomes in Patients With Cirrhosis and Coronavirus Disease-2019. | 2021 | Details |
| A50875 | 34675888 | Front Endocrinol (Lausanne) | Cardiovascular Endocrinology: Evolving Concepts and Updated Epidemiology of Relevant Diseases. | 2021 | Details |
| A50899 | 35783901 | Hepatol Forum | Causes of erectile dysfunction in non-alcoholic fatty liver disease. | 2021 | Details |